The Clorox Company (NYSE:CLX) Receives Average Recommendation of “Reduce” from Analysts

Shares of The Clorox Company (NYSE:CLXGet Free Report) have received an average recommendation of “Reduce” from the sixteen brokerages that are covering the stock, Marketbeat Ratings reports. Four investment analysts have rated the stock with a sell recommendation and twelve have given a hold recommendation to the company. The average 1-year target price among brokerages that have issued ratings on the stock in the last year is $149.38.

Several equities research analysts have issued reports on CLX shares. The Goldman Sachs Group started coverage on Clorox in a report on Friday, March 1st. They set a “sell” rating and a $140.00 price objective on the stock. Citigroup dropped their price objective on Clorox from $155.00 to $150.00 and set a “neutral” rating on the stock in a report on Wednesday. Jefferies Financial Group upgraded Clorox from an “underperform” rating to a “hold” rating and set a $145.00 price objective on the stock in a report on Tuesday, March 26th. Deutsche Bank Aktiengesellschaft dropped their price objective on Clorox from $155.00 to $151.00 and set a “hold” rating on the stock in a report on Wednesday, April 17th. Finally, JPMorgan Chase & Co. dropped their price objective on Clorox from $159.00 to $158.00 and set a “neutral” rating on the stock in a report on Wednesday.

Get Our Latest Stock Report on Clorox

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the business. abrdn plc boosted its position in Clorox by 20.1% during the 4th quarter. abrdn plc now owns 198,250 shares of the company’s stock worth $28,268,000 after acquiring an additional 33,135 shares during the period. International Assets Investment Management LLC boosted its position in Clorox by 17,658.5% during the 4th quarter. International Assets Investment Management LLC now owns 484,453 shares of the company’s stock worth $69,078,000 after acquiring an additional 481,725 shares during the period. Adage Capital Partners GP L.L.C. acquired a new position in Clorox during the 3rd quarter worth $6,605,000. Eagle Rock Investment Company LLC acquired a new position in Clorox during the 4th quarter worth $2,940,000. Finally, Federated Hermes Inc. boosted its position in Clorox by 483.8% during the 4th quarter. Federated Hermes Inc. now owns 27,696 shares of the company’s stock worth $3,949,000 after acquiring an additional 22,952 shares during the period. Institutional investors and hedge funds own 78.53% of the company’s stock.

Clorox Stock Performance

Clorox stock opened at $139.64 on Friday. The stock’s 50-day moving average is $149.00 and its 200-day moving average is $143.10. The company has a market cap of $17.33 billion, a price-to-earnings ratio of 221.65, a price-to-earnings-growth ratio of 2.35 and a beta of 0.43. The company has a debt-to-equity ratio of 11.37, a current ratio of 0.89 and a quick ratio of 0.57. Clorox has a 12 month low of $114.68 and a 12 month high of $178.21.

Clorox (NYSE:CLXGet Free Report) last released its quarterly earnings results on Tuesday, April 30th. The company reported $1.71 EPS for the quarter, topping the consensus estimate of $1.33 by $0.38. The firm had revenue of $1.81 billion for the quarter, compared to analyst estimates of $1.87 billion. Clorox had a return on equity of 319.41% and a net margin of 1.09%. Clorox’s revenue for the quarter was down 5.3% on a year-over-year basis. During the same period in the previous year, the company posted $1.51 EPS. Equities analysts anticipate that Clorox will post 5.52 earnings per share for the current year.

Clorox Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, May 10th. Investors of record on Wednesday, April 24th will be paid a dividend of $1.20 per share. The ex-dividend date of this dividend is Tuesday, April 23rd. This represents a $4.80 dividend on an annualized basis and a yield of 3.44%. Clorox’s payout ratio is currently 761.92%.

Clorox Company Profile

(Get Free Report

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Featured Stories

Analyst Recommendations for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.